<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04014933</url>
  </required_header>
  <id_info>
    <org_study_id>LSFG Repro</org_study_id>
    <nct_id>NCT04014933</nct_id>
  </id_info>
  <brief_title>Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System</brief_title>
  <acronym>LSFG Repro</acronym>
  <official_title>Prospective, Non-randomised, Non-controlled Study of Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cantonal Hosptial Aarau, Department of Ophthalmology, Aarau, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In addition to intraocular pressure blood perfusion pressure in the optic nerve is an
      important factor determing the cause of glaucoma. Increasing evidence suggests that in
      glaucoma patients retinal blood may be decreased.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to the World Health Organization (WHO) glaucoma is the second leading cause of
      blindness. Glaucoma is a global problem, which is becoming even more important as the human
      life expectancy increases. Although the causes of glaucoma are uncertain, mainly intraocular
      pression (IOP), genetics, and ocular blood perfusion pressure in the optic nerve determine
      the cause of the disease. Increasing evidence suggests that in glaucoma patients retinal
      blood flow is decreased leading to progression and to damage of the optic nerve.

      In order to measure the peripapillary blood flow a variety of devices using different
      techniques of flowmetry have been developed. In this study, the reproducibility of the
      retinal flowmetry measured with the LSFG-NAVI device from Nidek will be investigated. A high
      reproducibility is crucial for the clinical value of any measuring device.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 9, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Coefficients of variation (COV)</measure>
    <time_frame>1 month</time_frame>
    <description>COVs from 3 measurements of ocular blood flow at visit 1 of observer 1 and at visit 1 of observer 1 and from observer 2 will be computed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intraclass correlation coefficients (ICCs)</measure>
    <time_frame>1 month</time_frame>
    <description>Intraobserver ICC, interobserver ICC, and inter-session ICC will be computed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cofounder</measure>
    <time_frame>1 month</time_frame>
    <description>Blood pressure will be checked as potential cofounder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cofounder</measure>
    <time_frame>1 month</time_frame>
    <description>heart rate will be checked as potential cofounder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cofounder</measure>
    <time_frame>1 month</time_frame>
    <description>spherical equivalent will be checked as potential cofounder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cofounder</measure>
    <time_frame>1 month</time_frame>
    <description>intraocular pressure will be checked as potential cofounder</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <condition>Normal Tension Glaucoma</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>open-angle glaucoma</arm_group_label>
    <description>patients with a diagnosis of open-angle glaucoma, i.e. untreated IOP &gt;21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal tension glaucoma</arm_group_label>
    <description>patients with a diagnosis of normal tension glaucoma, i.e. untreated IOP &lt;/=21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <description>individuals with normal optic disc and IOP &lt;/21mmHg and normal visual fields</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>LASER SPECKLE FLOWGRAPHY</intervention_name>
    <description>Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region</description>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_label>normal tension glaucoma</arm_group_label>
    <arm_group_label>open-angle glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        3 groups as described above will be recruted from the outpatient department of the
        Ophthalmology Department at the UniversityHospital Zurich, Zurich, Switzerland and the
        Ophthalmology Department at the Cantonal Hospital Aarau, Aarau, Switzerland
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed Patient Informed Consent form

          -  Be at least 18 years old

          -  Diagnosis of primary or secondary open-angle glaucoma or normal tension glaucoma or
             healthy controls

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Inability to follow the procedures of the study, e.g. due to language problems,
             psychological disorders, dementia, etc. of the participant.

          -  No vulnerable participants will be included in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Töteberg-Harms, MD, FEBO</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc Töteberg-Harms, MD, FEBO</last_name>
    <phone>+41442558794</phone>
    <email>marc.toeteberg@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Funk, MD, PhD</last_name>
    <phone>+41442558794</phone>
    <email>jens.funk@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cantonal Hospital Aarau, Department of Ophthalmology</name>
      <address>
        <city>Aarau</city>
        <state>AG</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcel Menke, MD</last_name>
      <phone>+41 62 8385005</phone>
      <email>marcel.menke@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Markus Tschopp, MD</last_name>
      <phone>+41 62 8385005</phone>
      <email>augenklinik@ksa.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of Ophthalmology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Toeteberg-Harms, MD, FEBO</last_name>
      <phone>+41 44 255 - 1111</phone>
      <email>marc.toeteberg@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jens Funk, MD, PhD</last_name>
      <phone>+41 44 255 - 1111</phone>
      <email>jens.funk@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2019</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>retinal blood flow</keyword>
  <keyword>ocular perfusion pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Low Tension Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

